Measurement of total pulmonary arterial compliance using invasive pressure monitoring and MR flow quantification during MR-guided cardiac catheterization

Vivek Muthurangu, David Atkinson, Maxime Sermesant, Marc E. Miquel, Sanjeet Hegde, Robert Ian Johnson, Rado Andriantsimiavona, Andrew M. Taylor, Edward Baker, Robert Tulloh, David Hill, Reza RazaviAmerican 2005 · DOI

TL;DR

This paper presents a novel, minimally invasive method to measure total pulmonary arterial compliance in patients, combining MR-guided cardiac catheterization with invasive pressure monitoring and MR flow quantification. This technique offers a more complete hemodynamic assessment for pulmonary hypertensive disease, which is currently challenging to achieve clinically.

What Problem Does This Paper Address?

Pulmonary hypertensive disease is a serious condition characterized by increased pulmonary vascular resistance. While resistance is routinely measured, total pulmonary arterial compliance, another crucial indicator of the disease's severity and impact on the heart, is rarely assessed clinically due to measurement difficulties. Current methods are either too invasive, require specialized equipment, or are not suitable for patients with conditions like pulmonary regurgitation. This lack of comprehensive hemodynamic data can lead to inaccurate treatment decisions and predictions.

Methods

The researchers developed a method that integrates two key technologies:

  • MR-Guided Cardiac Catheterization: This allows for real-time visualization and manipulation of catheters within the heart and pulmonary arteries using an MRI scanner, often with X-ray backup for enhanced guidance.
  • Phase-Contrast Magnetic Resonance (PC-MRI) Flow Quantification: This MR technique accurately measures blood flow volume in the pulmonary artery.

During the MR-guided procedure, invasive pressure catheters were used to measure pulmonary arterial pressure (systolic, diastolic, and mean). Simultaneously, PC-MRI captured pulmonary artery flow data. Two methods were employed to calculate total arterial compliance:

  1. Ratio of Stroke Volume to Pulse Pressure (Csv): A simpler, though potentially overestimating, method.
  2. Pulse Pressure Method (Cppm): Based on parameter optimization of a two-element Windkessel model, considered a more accurate estimate. This method also required the calculation of pulmonary vascular resistance.

The study also investigated the response to inhaled nitric oxide (NO), a vasodilator, to assess changes in compliance and resistance.

Datasets

The study utilized data from 17 pediatric and adult patients undergoing MR-guided cardiac catheterization for suspected pulmonary hypertension or congenital heart disease. This patient cohort served as the dataset for evaluating the feasibility and accuracy of the proposed measurement technique. No new public benchmarks were introduced.

Key Insights and Ideas

  • Bridging the Gap: The core innovation is the successful integration of MR imaging and invasive hemodynamics to overcome the limitations of traditional compliance measurements.
  • Windkessel Model Validation: The study validates the use of the two-element Windkessel model (Cppm) for pulmonary arterial compliance estimation in vivo, correlating it well with a simpler method (Csv).
  • Compliance as a Key Indicator: The findings highlight the inverse relationship between pulmonary arterial compliance and both resistance and mean pulmonary arterial pressure, suggesting that reduced compliance is a significant factor in pulmonary hypertensive disease.
  • Nitric Oxide's Impact: The study observed that while inhaled NO significantly reduced resistance and pulse pressure, its effect on increasing total arterial compliance was less pronounced and not statistically significant at the population level, though individual responses were noted.

Key Results

  • Feasibility Demonstrated: The MR-guided cardiac catheterization approach successfully acquired simultaneous invasive pressure and PC-MRI flow data in all 17 patients.
  • Strong Agreement Between Methods: The two compliance estimation methods (Cppm and Csv) showed excellent agreement (r = 0.98, P < 0.001).
  • Systematic Bias: Despite good agreement, Csv consistently overestimated Cppm by a significant bias of 61%.
  • Inverse Relationship: A strong inverse correlation was found between compliance and resistance (r = 0.89, P < 0.001) and between compliance and mean pulmonary arterial pressure (r = 0.72, P < 0.001).
  • NO Response: In response to inhaled NO, a statistically significant fall in resistance, systolic pressure, and pulse pressure was observed. Seven patients showed an increase in total arterial compliance of >10%.

Limitations and Future Work

  • Small and Inhomogeneous Population: The study acknowledges that the small and diverse patient group limited the statistical power for analyzing responses to NO and the relationships between hemodynamic variables.
  • Anesthesia Effects: General anesthesia may have influenced the hemodynamic responses to NO.
  • Arrhythmias and Turbulent Flow: PC-MRI accuracy can be affected by arrhythmias or turbulent blood flow, though these were not encountered in this study.
  • Future Directions: The authors suggest that this technique could be applied to larger, more homogeneous patient groups to further investigate the relationship between compliance, pulmonary hypertensive disease, and medical interventions. They also propose that the technique could potentially be adapted for conventional cardiac MR scanners, expanding its clinical utility. The authors believe that measuring pulmonary arterial compliance will provide valuable insights into the pathophysiology of pulmonary hypertension and aid in assessing treatment suitability.

Summary updated

Abstract

Pulmonary hypertensive disease is assessed by quantification of pulmonary vascular resistance. Pulmonary total arterial compliance is also an indicator of pulmonary hypertensive disease. However, because of difficulties in measuring compliance, it is rarely used. We describe a method of measuring pulmonary arterial compliance utilizing magnetic resonance (MR) flow data and invasive pressure measurements. Seventeen patients with suspected pulmonary hypertension or congenital heart disease requiring preoperative assessment underwent MR-guided cardiac catheterization. Invasive manometry was used to measure pulmonary arterial pressure, and phase-contrast MR was used to measure flow at baseline and at 20 ppm nitric oxide (NO). Total arterial compliance was calculated using the pulse pressure method (parameter optimization of the 2-element windkessel model) and the ratio of stroke volume to pulse pressure. There was good agreement between the two estimates of compliance (r = 0.98, P < 0.001). However, there was a systematic bias between the ratio of stroke volume to pulse pressure and the pulse pressure method (bias = 61%, upper level of agreement = 84%, lower level of agreement = 38%). In response to 20 ppm NO, there was a statistically significant fall in resistance, systolic pressure, and pulse pressure. In seven patients, total arterial compliance increased >10% in response to 20 ppm NO. As a population, the increase did not reach statistical significance. There was an inverse relation between compliance and resistance (r = 0.89, P < 0.001) and between compliance and mean pulmonary arterial pressure (r = 0.72, P < 0.001). We have demonstrated the feasibility of quantifying total arterial compliance using an MR method.
BibTeX
@inproceedings{muthurangu2005measurement,
  author = {Vivek Muthurangu and David Atkinson and Maxime Sermesant and Marc E. Miquel and Sanjeet Hegde and Robert Ian Johnson and Rado Andriantsimiavona and Andrew M. Taylor and Edward Baker and Robert Tulloh and David Hill and Reza Razavi},
  title = {{Measurement of total pulmonary arterial compliance using invasive pressure monitoring and MR flow quantification during MR-guided cardiac catheterization}},
  booktitle = {American},
  year = {2005},
  doi = {10.1152/ajpheart.00957.2004},
}

Loading related content...

Figure